Several other research firms have also recently issued reports on DPLM. Berenberg Bank lowered their price objective on shares of Diploma from GBX 1,435 ($18.75) to GBX 1,350 ($17.64) and set a hold rating for the company in a research report on Tuesday, January 29th. Barclays boosted their price objective on shares of Diploma from GBX 1,190 ($15.55) to GBX 1,225 ($16.01) and gave the company an equal weight rating in a research report on Tuesday, November 20th. Finally, Royal Bank of Canada reissued a sector performer rating and issued a GBX 1,280 ($16.73) price objective on shares of Diploma in a research report on Monday, November 19th. Six investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. Diploma presently has a consensus rating of Hold and a consensus price target of GBX 1,356.43 ($17.72).
Shares of DPLM opened at GBX 1,324.74 ($17.31) on Monday. Diploma has a 52-week low of GBX 1,010 ($13.20) and a 52-week high of GBX 1,270 ($16.59).
The business also recently disclosed a dividend, which was paid on Wednesday, January 23rd. Shareholders of record on Thursday, November 29th were given a GBX 17.80 ($0.23) dividend. This represents a yield of 1.32%. This is a boost from Diploma’s previous dividend of $7.70. The ex-dividend date of this dividend was Thursday, November 29th.
In other Diploma news, insider Nigel Lingwood sold 115,723 shares of the business’s stock in a transaction dated Tuesday, January 29th. The shares were sold at an average price of GBX 1,261 ($16.48), for a total value of £1,459,267.03 ($1,906,790.84).
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in North America, Europe, and internationally. It operates through Life Sciences, Seals, and Controls business sectors. The Life Sciences sector supplies consumables and instruments for the diagnostic testing of blood, tissue, and other samples in hospital pathology laboratories; electrosurgery equipment and consumables for use in hospital operating rooms; and surgical medical devices, and related consumables and services to GI endoscopy suites in hospitals and private clinics.
Featured Article: Bear Market
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.